This paper examines the ethical and moral dimensions of Becton Dickinson's decision to withhold the Safety-Lok syringe in a limited range of sizes, despite possessing the technology to produce a full line. Drawing on utilitarian principles, rights theory, and justice frameworks, the paper argues that Becton Dickinson had a moral β if not legal β obligation to make the safety syringe fully available. It also considers the broader implications of the Maryann Rockwood case for corporate liability, manufacturer responsibility, patent law, and shared moral accountability among nurses, clinics, government, and industry. The paper concludes that public safety must take precedence over profit maximization.
While exempt from legal obligations to provide safety syringes in all sizes, Becton Dickinson did in fact have a moral obligation to offer its Safety-Lok syringes in the full range of sizes. While profit will always be the bottom line for a company of its kind, when people's lives are at stake, profit must take second place. From a caring perspective, the company should have recognized that a short-term reduction in profit would be a worthy sacrifice if it meant preventing the deaths of tens of thousands β or even millions β of people. Furthermore, such a decision would have established Becton Dickinson as an ethical leader in the healthcare products industry.
Consideration of rights complicates the matter, however, as Becton Dickinson also had a right to market only those products it deemed marketable and feasible to produce. A company cannot be expected to absorb indefinite profit losses without risking insolvency. Yet, based on the company's later decision to manufacture and market the syringes in all sizes β made only under competitive pressure β it is painfully clear that Becton Dickinson could have initially offered the full range of safety syringes.
Because so many nurses were unnecessarily exposed to disease as a result of Becton Dickinson withholding the technology, the company failed to follow the utilitarian principle of the greatest good for the greatest number. In practice, the only people who benefited from the company's decision were the executives who reaped the bulk of its profits. Finally, the deliberate withholding of the technology β both by not marketing the syringe in all sizes and by refusing to open patent rights to competitors β constitutes a violation of justice. Unfortunately, Becton Dickinson was able to hide behind legal loopholes.
Had Maryann Rockwood won her case at trial, the decision would have set a precedent prohibiting medical equipment manufacturers from withholding any technology or information pertaining to the safety and welfare of others. Companies need profits to remain in business; however, they must also be willing to occasionally lower their profit margins in the public interest. The implications of a successful lawsuit in this instance would have been enormously beneficial. The medical equipment and pharmaceutical industries too often operate in ways that are ethically questionable: although they manufacture goods that can save lives, corporate decisions are driven not by the welfare of patients and healthcare workers but primarily by profit. Legislation could prevent such unscrupulous business practices in the future.
"Whether patent holders must disclose life-saving technology"
"Distributing blame across nurse, clinic, government, and company"
You’re 56% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.